Daiichi Sankyo initiates Phase 3 trial for Destiny-Breast11 neoadjuvant therapy
Destiny-Breast11 will evaluate Enhertu as a monotherapy or Enhertu followed by paclitaxel, trastuzumab and pertuzumab
Destiny-Breast11 will evaluate Enhertu as a monotherapy or Enhertu followed by paclitaxel, trastuzumab and pertuzumab
According to the Russian Direct Investment Fund (RDIF), the Russian Sputnik V and Sputnik Light vaccines have proven to be highly effective against all variants of SARC-Cov-2
Vaccine effectiveness of complete vaccination against the moderate-to-severe disease was at 81 per cent
The Omicron variant, which was designated a variant of concern by the World Health Organization (WHO), has more than 30 mutations in the spike protein alone
It’s a two-dose vaccine administered 28 days apart
The company has has 10 existing labs in India
Maharashtra won the award for the highest number of deceased donors transplantations
Merck has shared these additional analyses with the FDA and they will be presented to the FDA’s Antimicrobial Drugs Advisory Committee on Nov. 30th
The campaign aims to increase awareness about Tuberculosis as a curable disease and promote early diagnosis.
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
Subscribe To Our Newsletter & Stay Updated